Jansen JH - Search Results

1

Clonal haematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls.

Salzbrunn JB, van Zeventer IA, de Graaf AO, Kamphuis P, van Bergen MGJM, van Sleen Y, van der Reijden BA, Schuringa JJ, Brouwer E, Diepstra A, Jansen JH, Huls G. Salzbrunn JB, et al. Among authors: jansen jh. Rheumatology (Oxford). 2024 Feb 1;63(2):e45-e47. doi: 10.1093/rheumatology/kead435. Rheumatology (Oxford). 2024. PMID: 37632778 Free PMC article. No abstract available.

2

Acute leukemias with structurally altered core binding factor subunits (t(8;21), inv(16), t(12;21)), 27-28 June 1997, Rotterdam, The Netherlands.

van der Reijden BA, Bloomfield CD, Touw IP, Jansen JH. van der Reijden BA, et al. Among authors: jansen jh. Leukemia. 1997 Dec;11(12):2217-9. Leukemia. 1997. PMID: 9447846

3

TRIADs: a new class of proteins with a novel cysteine-rich signature.

van der Reijden BA, Erpelinck-Verschueren CA, Löwenberg B, Jansen JH. van der Reijden BA, et al. Among authors: jansen jh. Protein Sci. 1999 Jul;8(7):1557-61. doi: 10.1110/ps.8.7.1557. Protein Sci. 1999. PMID: 10422847 Free PMC article.

4

Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676).

de Vetten MP, Jansen JH, van der Reijden BA, Berger MS, Zijlmans JM, Löwenberg B. de Vetten MP, et al. Among authors: jansen jh. Br J Haematol. 2000 Oct;111(1):277-9. doi: 10.1046/j.1365-2141.2000.02402.x. Br J Haematol. 2000. PMID: 11091212 Free article.

5

Degradable dU-based DNA template as a standard in real-time PCR quantitation.

Pennings JL, Van De Locht LT, Jansen JH, Van der Reijden BA, De Witte T, Mensink EJ. Pennings JL, et al. Among authors: jansen jh. Leukemia. 2001 Dec;15(12):1962-5. doi: 10.1038/sj.leu.2402290. Leukemia. 2001. PMID: 11753618

6

Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.

Van der Reijden BA, de Wit L, van der Poel S, Luiten EB, Lafage-Pochitaloff M, Dastugue N, Gabert J, Löwenberg B, Jansen JH. Van der Reijden BA, et al. Among authors: jansen jh. Hematol J. 2001;2(3):206-9. doi: 10.1038/sj.thj.6200103. Hematol J. 2001. PMID: 11920247

7

Bcl-2 protects against apoptosis induced by antimycin A and bongkrekic acid without restoring cellular ATP levels.

de Graaf AO, Meijerink JP, van den Heuvel LP, DeAbreu RA, de Witte T, Jansen JH, Smeitink JA. de Graaf AO, et al. Among authors: jansen jh. Biochim Biophys Acta. 2002 Apr 22;1554(1-2):57-65. doi: 10.1016/s0005-2728(02)00213-x. Biochim Biophys Acta. 2002. PMID: 12034471 Free article.

8

A novel, essential control for clonality analysis with human androgen receptor gene polymerase chain reaction.

van Dijk JP, Heuver LH, van der Reijden BA, Raymakers RA, de Witte T, Jansen JH. van Dijk JP, et al. Among authors: jansen jh. Am J Pathol. 2002 Sep;161(3):807-12. doi: 10.1016/S0002-9440(10)64240-X. Am J Pathol. 2002. PMID: 12213708 Free PMC article.

9

Bcl-2 prevents loss of mitochondria in CCCP-induced apoptosis.

de Graaf AO, van den Heuvel LP, Dijkman HB, de Abreu RA, Birkenkamp KU, de Witte T, van der Reijden BA, Smeitink JA, Jansen JH. de Graaf AO, et al. Among authors: jansen jh. Exp Cell Res. 2004 Oct 1;299(2):533-40. doi: 10.1016/j.yexcr.2004.06.024. Exp Cell Res. 2004. PMID: 15350550

10

Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?

de Graaf AO, de Witte T, Jansen JH. de Graaf AO, et al. Among authors: jansen jh. Leukemia. 2004 Nov;18(11):1751-9. doi: 10.1038/sj.leu.2403493. Leukemia. 2004. PMID: 15457181 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

317 results

Search Page

Filters